Related Experiment Video

Updated: Aug 29, 2026

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

[Pathogenic bacteria in cystic fibrosis]

P Mariani-Kurkdjian1, E Bingen

  • 1Service de microbiologie, hôpital Robert-Debré, AP-HP, 48, boulevard Sérurier, 75019 Paris, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|December 16, 2003
PubMed

Insights

Managing bronchopulmonary infections in cystic fibrosis (CF) patients is crucial for survival. Early antibiotic intervention prevents chronic colonization by bacteria like Pseudomonas aeruginosa, while long-term strategies combat multiresistant germs.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Genetics

Background:

  • Bronchopulmonary infection significantly impacts cystic fibrosis (CF) prognosis despite advances in understanding the disease.
  • Pseudomonas aeruginosa is a key pathogen following Staphylococcus aureus infection, contributing to lung deterioration in CF patients.
  • Other bacteria such as Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes sp. can also be involved.

Purpose of the Study:

  • To highlight the critical role of bacterial infections in cystic fibrosis (CF) patient outcomes.
  • To emphasize the importance of timely and strategic antibiotic interventions.
  • To discuss the necessity of long-term antibiotic strategies for managing chronic colonization and preventing antimicrobial resistance.

Main Methods:

  • Review of current knowledge on CF pathophysiology and microbial colonization.
  • Analysis of the impact of Staphylococcus aureus and Pseudomonas aeruginosa infections.
  • Evaluation of antibiotic treatment strategies for primary and chronic colonization.

Main Results:

  • Intensive antibiotic treatment for initial colonization can prevent or delay chronic bacterial presence.
  • Chronic colonization requires a rational, long-term antibiotic approach to prevent multi-drug resistant organisms.
  • Regular antibiotic treatments (every 3-4 months) are administered before symptom onset of pulmonary exacerbations.

Conclusions:

  • Effective management of bronchopulmonary infections is paramount for CF patient survival.
  • Early and strategic antibiotic use is essential to prevent chronic colonization and subsequent lung damage.
  • Long-term antibiotic strategies are necessary to combat multiresistant bacteria and improve patient prognosis in cystic fibrosis.

More Related Videos

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Bacterial Phylum Actinobacteria01:30

Bacterial Phylum Actinobacteria

Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...